Abstract
Adherence to Highly Active Antiretroviral Therapy (HAART) medication is an important predictor of a successful treatment and improvement of quality of life among People Living with Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS) (PLWHA). In the seven years before this study, several measures were taken to improve adherence to HAART among PLWHA at the study site, but no work has been published to establish the impact of the measures. We conducted a cross-sectional study among HIV-positive patients attending the antiretroviral clinic of State Specialist Hospital Yola, Adamawa State, Nigeria, in October-December 2019. Adherence was measured using self-report and was defined as taking at least ≥95% of the prescribed doses of Antiretroviral Therapy (ART) in the seven days preceding the survey. A total of 431 PLWHA participated in the study. There was an 88.4% adherence rate, and forgetfulness (62.2%) was the most common reason for missing HAART dosages. Adherence was found to be 92.1% (p=0.017) among those who have been on HAART for ˃2 years, 92.3% (p=0.01) among those not afraid of stigma, and 92.9% (p=0.002) among those who practice Islamic faith. Other factors associated with higher adherence included age less than 34 years, 91.2% (p=0.167), income of ˂₦30,000 per month, 88.6% (p=0.858), and less educated, 90.5% (p=0.852). The study showed adherence prevalence was 88.4%. Forgetfulness was found to be the most common reason for missing HAART dosages. We therefore recommend the introduction of medication adherence reminders into the HIV programs.
Reference26 articles.
1. Cobucci RNO, Lima PH, Souza PC de, et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Journal of Infection and Public Health 2015;8:1-10.
2. Yaya I, Landoh DE, Saka B, et al. Predictors of adherence to antiretroviral therapy among People Living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health 2014;14:1308.
3. Olowookere SA, Fatiregun AA, Akinyemi JO, et al. Prevalence and determinants of nonadherence to Highly Active Antiretroviral Therapy among People Living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries 2008;2:369-72.
4. Fielden SJ, Rusch MLA, Yip B, et al. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. J Int Assoc Physicians AIDS Care (Chic) 2008;7:238-44.
5. Abdulsamad H, Oche OM, Raji MO, Mohammed Y. Prevalence and factors associated with treatment adherence among patients on Highly Active Antiretroviral Therapy (HAART) in Specialist Hospital, Sokoto, Nigeria. International Archives of Medical and Health Research 2019;1:7.